Effect of Omega‐3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. n‐3 polyunsaturated fatty acids (n‐3‐PUFAs) have been reported to ameliorate the progression of NAFLD in experimental studies; however, clinical trials have yielded contradictory results. The aim of our study was to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Šmíd, Václav, Dvořák, Karel, Šedivý, Petr, Kosek, Vít, Leníček, Martin, Dezortová, Monika, Hajšlová, Jana, Hájek, Milan, Vítek, Libor, Bechyňská, Kamila, Brůha, Radan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134818/
https://www.ncbi.nlm.nih.gov/pubmed/35147302
http://dx.doi.org/10.1002/hep4.1906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134818/
https://www.ncbi.nlm.nih.gov/pubmed/35147302
http://dx.doi.org/10.1002/hep4.1906

Ejemplares similares